Cytori Therapeutics (CYTX) Stock Climbs On China Regulatory Clearance


Cytori stock newsCytori Therapeutics Inc (NASDAQ: CYTX)

CYTX stock is flying high today on positive news from China. The company announced that its exclusive licensee, Lorem Vascular, was granted by the State Food and Drug Administration of the People’s Republic of China. This is huge news for Cytori as China is currently the largest health care market in the world; and now, Cytori’s Celution System will be available in that market.

What This Means For CYTX

This is great news for Cytori Therapeutics. The bottom line is that by making their treatment available in China, their sales have no where to go, but up. Since investors like to see revenue flowing, this means that the current investors are happy, and new investors will be interested as the company continues to show more and more sales.

What We’ve Seen From Cytori Today

Today, Cytori Therapeutics stock was soaring in morning trading; reaching a high today so far of $1.40 per share. However, since the big morning spike, growth seems to be correcting and the company’s stock has fallen to $1.32 per share so far (11:04). Nonetheless, it’s still very clear that unless some major negative news comes out about the company between now and the closing bell, we’re going to see a close in the green today.

CYTX Outlook

Moving forward, I think we’re going to see growth on a long term scale from Cytori Therapeutics. While it’s important to remember that in the small-cap biotech space, we will see a bit of market volatility; it’s also clear that the company is making big moves to get it’s medications in other areas and increase revenue. So, I definitely see this one moving up over the long run.

What Do You Think?

Where do you think CYTX is headed? Let us know in the comments below.


Please enter your comment!
Please enter your name here